You lead launch planning and enhance commercial effectiveness for treatments in rare diseases, coordinating analytics and cross-functional teams to drive insights and optimize resource management.
Anforderungen
- •Master’s degree or equivalent
- •At least 10 years of experience
- •Prior experience with indirect leadership
- •Fluency in English
- •Proficient in additional languages preferred
- •Strong collaborative ability
- •Independent and proactive mindset
- •Intellectual curiosity and creativity
- •Accountable for high-quality results
Deine Aufgaben
- •Lead global launch planning for somapacitan.
- •Oversee resource allocation and sales forecasting for GHT.
- •Drive effectiveness in commercial operations.
- •Manage Launch and Execution Group for GHT.
- •Ensure alignment on launch strategies and market entry.
- •Lead Rare Disease Commercial Analytics function.
- •Implement data-driven strategies and drive insights adoption.
- •Manage relationships with strategic partners and vendors.
- •Integrate new data sources for improved analytics.
Original Beschreibung
# Director, Global Launch & Commercial Excellence Rare Disease
Category:
Commercial Marketing
Location:
Zurich, Switzerland Zurich, CH
Ready to lead game-changing launches in rare diseases?
At Novo Nordisk, you’ll drive global strategy, power commercial insights, and shape the future of care—turning bold ambition into real impact.
**The Position**
This position will give you the opportunity to lead the cross-functional launch process from start to finish, contribute to business strategy within the Rare Endocrine therapy area, and steer commercial analytics across Rare Diseases. You will work closely with global teams, strengthen cross-country collaboration, and drive data-driven insights to build a competitive advantage within the global focus markets. This is your chance to shape the future of patient care in an innovative and dynamic environment.
Key Responsibilities:
* Global Launch Leadership for somapacitan: Lead the full launch planning process, from pre-launch framework development to post-launch execution, ensuring alignment and readiness across functions.
* Commercial Effectiveness & Resource Management: Drive commercial success by overseeing resource allocation, sales forecasting, and KPIs for Growth Hormone Therapy (GHT), while optimizing field force effectiveness and commercial operations.
* Cross-functional Collaboration: Lead the cross-functional Launch and Execution Group (CLG) for GHT, ensuring alignment on launch strategies, sequencing, and organizational readiness for market entry.
* Strategic Analytics Leadership: Lead the Rare Disease (RareD) Commercial Analytics function, with the support from our colleagues in Global Business Services (GBS), ensuring the successful implementation of data-driven strategies and driving adoption of insights across the organization.
* Stakeholder & Vendor Management: Manage relationships with strategic partners, vendors, and internal stakeholders, while advancing the integration of new data sources to continuously improve analytics capabilities and decision-making.
**Qualifications**
* Master’s degree or equivalent in business, pharma, consulting, or a related field.
* Minimum of 10 years' experience in commercial, launch, commercial excellence (CE), or analytical roles.
* Prior experience with indirect leadership and Global Business Services (GBS) is a plus.
* Fluency in English; proficiency in additional languages is an advantage.
* Strong ability to collaborate and drive change across departments, engaging stakeholders from HQ, NOA, IO, regions, and key affiliates.
* Independent, proactive, and results-driven with a focus on continuous improvement and simplification opportunities.
* Intellectual curiosity with the ability to think creatively and take initiative to solve complex problems.
* Accountable and capable of delivering high-quality results while meeting deadlines.